TAG:
managed care contract
Will “Free Testing” Ploy Financially Affect Labs?
By Robert Michel | From the Volume IX No. 12 – August 26, 2002 Issue
CEO SUMMARY: It’s a marketing scheme which public lab companies have quietly used for years. Now there is evidence that the use of “Waiver of Charges to Managed Care Patients” (free testing) seems to be on the increase, raising new questions about how and why competitive practices a…
Big Premium Increases Drive Higher Profits at Nation’s HMOs
By Robert Michel | From the Volume IX No. 11 – August 5, 2002 Issue
EVEN AS EMPLOYERS COMPLAIN about spiraling healthcare costs, the nation’s biggest health insurers are enjoying robust profits. That brings up the interesting question about whether providers, including laboratories, can get better pricing during the next year, since HMOs are again profita…
Two New Public Labs Launch Operations in FL
By Robert Michel | From the Volume IX No. 10 – July 15, 2002 Issue
CEO SUMMARY: In 49 states, independent commercial laboratory companies are disappearing. But that’s not the case in Florida. In recent months, two new public laboratory companies completed organizational steps and now offer diagnostic testing services. Both companies are starting small,…
Is Physicians’ Office Testing Evolving Toward an Oligopoly?
By Robert Michel | From the Volume IX No. 7 – May 13, 2002 Issue
CEO SUMMARY: One of the most unpopular industries with consumers is the airline industry. At the national level, it is an oligopoly—dominated by seven carriers. But in many cities, it is a monopoly, with one airline flying 80% of the seats in and out of town. Ongoing consolidation of re…
Quest Pays $1.1 Billion To Acquire Unilab Corp.
By Robert Michel | From the Volume IX No. 6 – April 22, 2002 Issue
CEO SUMMARY: Quest Diagnostics Incorporated is showing its muscle. The dust had hardly settled on its $500 million acquisition of American Medical Laboratories when the lab industry’s behemoth announced that it would pay $1.1 billion to buy Unilab, by far the largest lab testing company…
Why Can’t Hospital Laboratories Collaborate?
By R. Lewis Dark | From the Volume IX No. 4 – March 11, 2002 Issue
MOST PEOPLE KNOWLEDGEABLE ABOUT THE INNER WORKINGS of the clinical laboratory industry generally agree that hospital laboratories possess inherent advantages over commercial laboratories—anytime a hospital lab outreach program is organized properly and marketed professionally. Certainly the manage…
Michigan Lab Network Wins Major HMO Deal
By Robert Michel | From the Volume IX No. 4 – March 11, 2002 Issue
CEO SUMMARY: By winning the contract for Health Alliance Plan (HAP), Joint Venture Hospital Laboratories (JVHL) captured another major exclusive managed care contract for lab testing services in Southeast Michigan. Its victory demonstrates that local hospital lab outreach programs can com…
Clinical Labs Discover Benchmarking
By R. Lewis Dark | From the Volume IX No. 1 – January 7, 2002 Issue
IN OUR MANY YEARS OF SERVICE to the clinical lab industry and the pathology profession, THE DARK REPORT has consistently been first to identify important trends and explain their relevance to those responsible for managing the nation’s laboratories. Back in 1995, we predicted that the (then) thre…
2001’s Ten Big Stories Presage Future Direction
By Robert Michel | From the Volume VIII No. 17 – December 17, 2001 Issue
CEO SUMMARY: During 2001, few labs found themselves under intense pressure to change or react to dramatic events in the healthcare marketplace. Like 2000, this past year was marked by evolutionary progress, not revolutionary change. However, continuing signs indicate that consumers will p…
Quest Buys New Jersey Lab, Lab Investors Cash In Stock
By Robert Michel | From the Volume VIII No. #15 – November 5, 2001 Issue
THERE’S LOTS OF BUYING and selling taking place among the public laboratory companies. On one side of the spectrum, Quest Diagnostics Incorporated announced the acquisition of Clinical Diagnostic Services, Inc., a private laboratory company based in Englewood, New Jersey. Clinic…
CURRENT ISSUE

Volume XXXII, No. 6 – April 21, 2025
Now that a federal judge has vacated the FDA’s LDT rule, The Dark Report analyzes the judgement and notes the various steps the FDA could take in response. Also, lab testing at pharmacies is proving to be less successful than was once anticipated.
See the full table of contentsHow Much Laboratory Business Intelligence Have You Missed?
Lab leaders rely on THE DARK REPORT for actionable intelligence on important developments in the business of laboratory testing. Maximize the money you make-and the money you keep! Best of all, it is released every three weeks!
Sign up for TDR Insider
Join the Dark Intelligence Group FREE and get TDR Insider FREE!
Never miss a single update on the issues that matter to you and your business.
Topics
- Anatomic Pathology
- Clinical Chemistry
- Clinical Laboratory
- Clinical Laboratory Trends
- Digital Pathology
- Genetic Testing
- In Vitro Diagnostics
- IVD/Lab Informatics
- Lab Intelligence
- Lab Marketplace
- Lab Risk & Compliance
- Laboratory Automation
- Laboratory Billing
- Laboratory Compliance
- Laboratory Equipment
- Laboratory Information Systems
- Laboratory Management
- Lean Six Sigma
- Managed Care Contracts
- Molecular Diagnostics
- Pathology Trends
- People
- Uncategorized